Xiamen Amoytop Biotech Co., Ltd. (SHA:688278)

China · Delayed Price · Currency is CNY

65.42

+1.03 (1.60%)

Mar 24, 2026, 11:29 AM CST

Revenue by Segment

Financials in millions CNY. Fiscal year is January - December.

Millions CNY. Fiscal year is Jan - Dec.

Fiscal Year	FY 2025	FY 2024	FY 2023	FY 2022	FY 2021	FY 2020	FY 2019	FY 2018	FY 2017	FY 2016
Period Ending	Dec '25 Dec 31, 2025	Dec '24 Dec 31, 2024	Dec '23 Dec 31, 2023	Dec '22 Dec 31, 2022	Dec '21 Dec 31, 2021	Dec '20 Dec 31, 2020	Dec '19 Dec 31, 2019	Dec '18 Dec 31, 2018	Dec '17 Dec 31, 2017	Dec '16 Dec 31, 2016
Biologics	3.70B	2.82B	2.10B	1.53B	1.13B
Biologics Growth	31.18%	34.13%	37.55%	34.86%	42.61%
Total	3.70B	2.82B	2.10B	1.53B	1.13B
Total Growth	31.18%	34.13%	37.55%	34.86%	42.61%

Revenue by Geography

Financials in millions CNY. Fiscal year is January - December.

Millions CNY. Fiscal year is Jan - Dec.

Fiscal Year	FY 2024	FY 2023	FY 2022	FY 2021	FY 2020	FY 2019	FY 2018	FY 2017	FY 2016
Period Ending	Dec '24 Dec 31, 2024	Dec '23 Dec 31, 2023	Dec '22 Dec 31, 2022	Dec '21 Dec 31, 2021	Dec '20 Dec 31, 2020	Dec '19 Dec 31, 2019	Dec '18 Dec 31, 2018	Dec '17 Dec 31, 2017	Dec '16 Dec 31, 2016
East China	921.29M	-	-	-
Central China	408.76M	-	-	-
Southwest China	448.52M	-	-	-
South China	306.40M	-	-	-
Northeast China	97.59M	-	-	-
North China	390.05M	-	-	-
Northwest China	233.14M	-	-	-
Overseas	3.66M	-	-	-
Total	2.81B	-	-	-

Source: S&P Global Market Intelligence.